ISSN 2147-9720 | E-ISSN 2148-4279
Case Report
Methorexate therapy in a patient with rheumatoid arthritis complicated by idiopathic thrombocytopenic purpura
(Eur J Rheumatol 2015; 2: 39-40)
DOI: 10.5152/eurjrheumatol.2014.14065
Successful treatment of Acrodermatitis continua of Hallopeau associated with psoriatic arthritis with adalimumab
(Eur J Rheumatol 2015; 2: 78-79)
DOI: 10.5152/eurjrheum.2015.0072
Therapy resistant idiopathic scleredema: an underlying pathology not always present
(Eur J Rheumatol 2015; 2: 163-164)
DOI: 10.5152/eurjrheum.2015.0004
Spontaneous regression of Epstein-Barr virus-associated lymphoproliferative disorder in a juvenile idiopathic arthritis patient after the discontinuation of methotrexate and etanercept
(Eur J Rheumatol 2017; 4: 136-138)
DOI: 10.5152/eurjrheum.2016.032
Visceral Leishmaniasis in a patient with rheumatoid arthritis undergoing treatment with methotrexate: Case report and review of the literature
(Eur J Rheumatol 2017; 4: 139-141)
DOI: 10.5152/eurjrheum.2017.16066
Refractory optic perineuritis due to granulomatosis with polyangiitis successfully treated with methotrexate and mycophenolate mofetil combination therapy
(Eur J Rheumatol 2017; 4: 70-72)
DOI: 10.5152/eurjrheum.2016.028
Cavitary pulmonary nodules in rheumatoid arthritis; case reports and review of the literature
(Eur J Rheumatol 2018; 5: 65-68)
DOI: 10.5152/eurjrheum.2017.16106
Original Article
Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison
(Eur J Rheumatol 2019; 6: 113-121)
DOI: 10.5152/eurjrheum.2019.19057
Early detection of spondyloarthropathy in patients with psoriasis by using the ultrasonography and magnetic resonance image
(Eur J Rheumatol 2015; 2: 10-15)
DOI: 10.5152/eurjrheumatol.2015.0075
Real-life experience of using conventional diseasemodifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA...
(Eur J Rheumatol 2017; 4: 1-10)
DOI: 10.5152/eurjrheum.2017.1608
Using subcutaneous methotrexate to prolong duration of methotrexate therapy in rheumatoid arthritis
(Eur J Rheumatol 2018; 5: 85-91)
DOI: 10.5152/eurjrheum.2018.17113
Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis
(Eur J Rheumatol 2017; 4: 40-45)
DOI: 10.5152/eurjrheum.2017.16052
Using subcutaneous methotrexate to prolong duration of methotrexate therapy in rheumatoid arthritis
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.17113
Invited Review
Targeting IL-17 in psoriatic arthritis
(Eur J Rheumatol 2017; 4: 272-277)
DOI: 10.5152/eurjrheum.2017.17037
Literature Review
Management of the temporomandibular joint in inflammatory arthritis: Involvement of surgical procedures
(Eur J Rheumatol 2017; 4: 151-156)
DOI: 10.5152/eurjrheum.2016.035
Key Words
Author’s Corner
AVES | Copyright © 2019 Medical Research and Education Association | Latest Update: 24.07.2019